Eugene Investment Securities, in a report issued on May 11, set a target price for Hecto Innovation at 28,000 won and maintained a buy investment view. Eugene Investment Securities said Hecto Innovation surpassed the 100 billion won level in first-quarter revenue and continues its growth trend.
Park Jong-seon (박종선), a researcher at Eugene Investment Securities, said preliminary consolidated results for Hecto Innovation in 2026 first quarter showed revenue of 112.3 billion won and operating profit of 14.6 billion won. Revenue rose about 25 percent from a year earlier, achieving a record quarterly high and surpassing the 100 billion won level for the first time, he said. Operating profit increased about 24 percent, he said.
Park said a positive point in the first-quarter results was that all business divisions maintained growth while not only setting a record quarterly high but also surpassing the 100 billion won level for the first time.
He cited IT information services, fintech and healthcare as factors behind revenue growth. On the fintech business, Park said it achieved a record quarterly high of 51.2 billion won in revenue, and that the high-margin easy cash payment service grew due to an inflow of new merchants, contributing to earnings growth and improved profitability.
He also said the healthcare business achieved a record high revenue of 24.7 billion won through an expanded lineup of new products and diversification of distribution channels. He said it was also positive that tailored new products, including 'Desimone Kids Yogurt', expanded the core customer base.
Eugene Investment Securities forecast stable growth would continue in the second quarter. Park said stable growth is expected while maintaining quarterly revenue at the 100 billion won level. He also said the target price of 28,000 won implies about 40 percent upside from the current share price, and that the current share price is trading at a discount, with a 2026 expected PER of 6.6 times compared with the average PER of 9.0 times for similar domestic companies.